EFFECTS OF PROPOLIS AND ROYAL JELLY SUPPLEMENTATION ON INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversidade Federal Fluminense

About this trial

The study aims to evaluate the effect of the royal jelly and propolis on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.

Eligibility criteria

Qualifiers

Diagnosis of stage 1 and 2 hypertension

Regular treatment for more than 6 months

There have been no changes in medication doses over the last three months.

Disqualifiers

Autoimmune and infectious diseases, diabetes

Chronic kidney disease, liver disease, cancer and AIDS

Pregnant women

Use of catabolic drugs or antibiotics

Trial design

Treatments tested in this trial

  • Placebo
  • Royal Jelly + Propolis Group

Treatment groups

48 Participants
are divided into 2 treatment groups